Belgium - Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector
Since 2014, Belgium Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector remained stable. With €0.1 Million in 2017, the country was number 1 comparing other countries in Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector. Belgium witnessed the best average annual growth at a stable, while Belgium witnessed the worst performance at a stable.
Loading...
| Date | Million Euros |
|---|---|
| 2017 | 0.10 |
| 2016 | 0.10 |
| 2015 | 0.10 |
| 2014 | 0.10 |
Download all data from 2014 to 2017
How does Belgium rank in Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector?
| # | 2 Countries | Million Euros | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Belgium
|
0.10 | 2017 | +0.0 % | +0.0 % | View data |
| 1 |
#1
Germany
|
0.10 | 2017 | +0.0 % | +0.0 % | View data |